VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 215 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,994,321 | -84.5% | 212,841 | -59.5% | 0.00% | -100.0% |
| Q2 2023 | $12,896,966 | +23.8% | 525,763 | +17.4% | 0.00% | -33.3% |
| Q1 2023 | $10,419,259 | +212.1% | 447,755 | +239.5% | 0.00% | – |
| Q4 2022 | $3,338,541 | -48.3% | 131,906 | -60.6% | 0.00% | -100.0% |
| Q3 2022 | $6,454,000 | -15.5% | 334,784 | +11.7% | 0.00% | 0.0% |
| Q2 2022 | $7,634,000 | -50.9% | 299,719 | -50.5% | 0.00% | -33.3% |
| Q1 2022 | $15,563,000 | -63.7% | 605,078 | -40.8% | 0.00% | – |
| Q4 2021 | $42,816,000 | +122.4% | 1,022,568 | +131.2% | 0.00% | -100.0% |
| Q3 2021 | $19,251,000 | -14.0% | 442,355 | -6.5% | 0.00% | -25.0% |
| Q2 2021 | $22,377,000 | +34.5% | 473,285 | +45.8% | 0.00% | +33.3% |
| Q1 2021 | $16,641,000 | +14.6% | 324,569 | -40.2% | 0.00% | +200.0% |
| Q4 2020 | $14,522,000 | +152.9% | 542,320 | +224.2% | 0.00% | – |
| Q3 2020 | $5,743,000 | -58.7% | 167,282 | -50.7% | 0.00% | -100.0% |
| Q2 2020 | $13,906,000 | +1171.1% | 339,422 | +963.5% | 0.00% | – |
| Q1 2020 | $1,094,000 | – | 31,917 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD | 22,616,666 | $284,405,000 | 3.12% |
| INDUS CAPITAL PARTNERS, LLC | 681,936 | $8,575,000 | 1.68% |
| Alphabet Inc. | 1,666,666 | $20,958,000 | 1.27% |
| Temasek Holdings (Private) Ltd | 5,499,999 | $69,162,000 | 0.45% |
| Board of Trustees of The Leland Stanford Junior University | 38,905 | $490,000 | 0.06% |
| Baillie Gifford | 500,000 | $6,287,000 | 0.01% |
| Marshall Wace North America L.P. | 74,898 | $941,000 | 0.01% |
| Capital International Investors | 983,300 | $12,365,000 | 0.00% |
| Blackstone Inc. | 35,000 | $440,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,908 | $24,000 | 0.00% |